What did @kaseytwyman actually say?
Honestly, not much, at least not in words that translate. The transcript captured in this video is essentially incoherent audio, likely background music lyrics rather than any spoken claim from the creator. What we do have is the caption: "Seeing my collarbone is such a new flex for me" paired with hashtags including #tirzepatide, #ozempicface, and #glp1community. So the message being sent to 716,000-plus viewers is visual and emotional: tirzepatide changed my body in a visible way, and I'm happy about it.
That's a real claim, even without a spoken word. The implication is that GLP-1 receptor agonist therapy, specifically tirzepatide, produced meaningful fat loss visible at the collarbone and face. That's worth examining carefully, because millions of people are making medical decisions based on exactly this kind of content.
Does the science back this up?
Yes, with important nuance. Tirzepatide does produce significant weight loss, and that loss does show up in the face and upper body. But the specifics matter more than the vibe.
The SURMOUNT-1 trial (Jastreboff et al., 2022, New England Journal of Medicine) found that participants taking tirzepatide 15mg lost an average of 20.9% of body weight over 72 weeks. That is not subtle. Changes at that scale absolutely become visible at the collarbone, jaw, and face, which is what #ozempicface refers to informally. A 2023 analysis in Obesity Reviews (Rubino et al.) confirmed that facial fat redistribution is a real and commonly reported phenomenon with significant GLP-1-driven weight loss, though it is not universally welcomed by patients.
So the visual transformation implied here? Backed by data. The drug works. The question is always what else comes with it, and whether social media framing gives the full picture.
What did they get wrong (or right)?
To be fair, @kaseytwyman didn't make a specific medical claim here. There is no dosing advice, no promise of a cure, no misleading comparison between compounded and brand-name tirzepatide. It is a before-and-after emotional moment shared with a large audience. That restraint, intentional or not, matters.
What the video gets implicitly wrong is the framing of effortlessness. Hashtags like #thriving and #happy, combined with a striking physical transformation, contribute to a broader social media pattern that strips away the clinical reality. Tirzepatide causes nausea, vomiting, constipation, and gastrointestinal distress in a significant portion of users. The SURMOUNT-1 trial reported that 82.7% of participants on the highest dose experienced GI side effects. None of that is in the caption. The #wellnessjourney framing also sidesteps the fact that this is a prescription medication requiring medical supervision, not a lifestyle product.
The #ozempicface hashtag is also worth flagging. It conflates semaglutide (Ozempic/Wegovy) with tirzepatide (Mounjaro/Zepbound). These are different drugs with different mechanisms. Grouping them under one aesthetic hashtag is sloppy at best.
What should you actually know?
Tirzepatide is a dual GIP and GLP-1 receptor agonist, which is why its weight loss results tend to outperform older GLP-1 drugs in head-to-head data. The SURMOUNT-4 trial (Aronne et al., 2024, JAMA) showed that people who stopped tirzepatide regained most of their lost weight within a year. That is not a criticism of the drug. It reflects that obesity is a chronic condition requiring ongoing management, not a problem you solve once and flex about.
Visible changes like a more prominent collarbone are real outcomes for many patients. But they arrive alongside a medical regimen, regular check-ins, and side effect management. Social media posts, even honest ones, tend to show the result without the clinical process that produced it. If you are considering a GLP-1 medication because of content like this, talk to a licensed provider who can evaluate your full health picture before prescribing anything.
- GLP-1 drugs are prescription medications, not wellness supplements.
- Results vary significantly based on dose, adherence, diet, and individual metabolism.
- Stopping the medication typically results in weight regain without lifestyle changes.
- Facial fat loss, the so-called Ozempic face, is real but not universal.